BioSig Technologies Files 8-K with Material Agreement Details
Ticker: STEX · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, 8-k, financials
Related Tickers: BSGM
TL;DR
BioSig Tech (BSGM) filed an 8-K on 3/5/25 for a material agreement - check it out.
AI Summary
On March 5, 2025, BioSig Technologies, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements/exhibits. The company, incorporated in Delaware, is in the electromedical and electrotherapeutic apparatus industry.
Why It Matters
This filing provides crucial updates on significant agreements and financial information for BioSig Technologies, Inc., impacting investors' understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant corporate news, but the specific details of the material agreement are not fully disclosed in this summary, requiring further review.
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- March 5, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement filed by BioSig Technologies, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details are not provided in the summary.
When was this 8-K filing submitted?
The filing was submitted on March 5, 2025.
What is BioSig Technologies, Inc.'s primary industry?
BioSig Technologies, Inc. is in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, SIC code 3845.
Where is BioSig Technologies, Inc. incorporated?
The company is incorporated in Delaware.
What is the principal executive office address for BioSig Technologies, Inc.?
The principal executive offices are located at 12424 Wilshire Blvd, Suite 745, Los Angeles, CA 90025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding BioSig Technologies, Inc. (STEX).